Foster & Motley Inc. increased its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 3.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 31,146 shares of the technology company’s stock after purchasing an additional 1,075 shares during the quarter. Foster & Motley Inc.’s holdings in Amdocs were worth $2,652,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in DOX. Private Trust Co. NA boosted its holdings in Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after purchasing an additional 117 shares during the last quarter. Brooklyn Investment Group purchased a new position in shares of Amdocs during the 3rd quarter worth $28,000. Catalyst Capital Advisors LLC purchased a new position in shares of Amdocs during the 3rd quarter worth $55,000. GAMMA Investing LLC boosted its stake in shares of Amdocs by 115.1% during the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after acquiring an additional 428 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in shares of Amdocs during the 3rd quarter worth $77,000. Hedge funds and other institutional investors own 92.02% of the company’s stock.
Amdocs Stock Up 1.3 %
Shares of DOX stock opened at $87.46 on Friday. The company has a market capitalization of $9.87 billion, a price-to-earnings ratio of 20.63, a PEG ratio of 1.42 and a beta of 0.71. Amdocs Limited has a one year low of $74.41 and a one year high of $94.04. The company’s fifty day moving average price is $85.87 and its 200-day moving average price is $86.25. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.20.
Amdocs Dividend Announcement
Analyst Ratings Changes
Several research analysts have recently weighed in on DOX shares. StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Oppenheimer lifted their price target on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Finally, Barclays dropped their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $101.20.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- Are Penny Stocks a Good Fit for Your Portfolio?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.